Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

generic drugs

Founded in 2001 and listed in Hong Kong in 2010, Sihuan originally specialized in the production of cardiovascular and oncology generic drugs, and is one of the largest cardiovascular prescription drug suppliers in China.

FAST NEWS: Sihuan Pharma stock skyrockets on latest share buyback program

The Latest: Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) on Sunday announced a new program to purchase up to HK$500 million ($64 million) worth of its shares on the open market over the next…
October 7, 2024
0460.HK
Sihuan Pharmaceutical announced Wednesday it expects to record a loss before tax of no more than 40 million yuan from continuing operations in the first half of this year.

FAST NEWS: Sihuan Pharma turns red, but medical aesthetic business improves

The latest: Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) announced Wednesday it expects to record a loss before tax of no more than 40 million yuan ($5.6 million) from continuing operations in the…
August 3, 2023
0460.HK

FAST NEWS: CMS Holdings Profit Rises as It Explores Medical Aesthetics

The latest: Drug maker China Medical System Holdings Ltd. (CMS Holdings) (0867.HK) on Wednesday evening said its net profit rose 19.2% last year to 3.02 billion yuan ($474 million), and…
March 16, 2022

Recent Articles

Founded in 2001 and listed in Hong Kong in 2010, Sihuan originally specialized in the production of cardiovascular and oncology generic drugs, and is one of the largest cardiovascular prescription drug suppliers in China.
October 7, 2024

FAST NEWS: Sihuan Pharma stock skyrockets on latest share buyback program

0460.HK
August 3, 2023

FAST NEWS: Sihuan Pharma turns red, but medical aesthetic business improves

0460.HK
March 16, 2022

FAST NEWS: CMS Holdings Profit Rises as It Explores Medical Aesthetics

RELATED ARTICLES

  1. Xuanzhu Biopharm set for spin-off in Hong Kong IPO
    December 5, 2024
    Xuanzhu Biopharm set for spin-off in Hong Kong IPO
    0460.HK
  2. March 6, 2025
    Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK
  3. December 19, 2024
    Hengrui Pharma accelerates bid for global brand status
    600276.SHG
  4. December 12, 2024
    BRIEF: JinkoSolar expands share buyback program
    JKS.US 688223.SHG
  5. December 13, 2024
    Innogen Pharma jostles for a slice of the weight-loss market
  6. December 2, 2024
    Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  7. February 27, 2025
    Airdoc Tech enjoys healing properties of medical AI rally
    2251.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Premium Content
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2024 Bamboo Works. All rights reserved.